Biomerica stockholders elect all 5 director nominees, approve share increase from 25M to 300M at 2025 annual meeting

BIOMERICA INC

All five director nominees elected with majority votes: Irani, Barbieri, Bing Chin, Huff, Moatazedi.
Non-binding advisory vote on executive compensation passed (411,157 for, 87,344 against).
Ratification of Haskell & White LLP as independent auditor for FY ending May 31, 2026 approved (1,472,716 for).
Amendment to 2024 Stock Incentive Plan to increase shares by 200,000 approved (371,339 for).
Amendment to Certificate of Incorporation to increase authorized common stock from 25M to 300M approved (1,028,102 for).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.